MENLO PARK, Calif., May 28, 2025 (GLOBE NEWSWIRE) — PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, announced today that management will be participating in the following upcoming investor conferences:
Live webcasts of the events can be accessed at the company’s investors page at investor.pacificbiosciences.com. A replay of the webcasts will be available for at least 30 days following the event.
About PacBio
PacBio (NASDAQ: PACB) is a premier life science technology company that designs, develops, and manufactures advanced sequencing solutions to help scientists and clinical researchers resolve genetically complex problems. Our products and technologies, which include our HiFi long-read sequencing, address solutions across a broad set of research applications including human germline sequencing, plant and animal sciences, infectious disease and microbiology, oncology, and other emerging applications. For more information, please visit www.pacb.com and follow @PacBio.
PacBio products are provided for Research Use Only. Not for use in diagnostic procedures.
Contacts
Investors:
Todd Friedman
ir@pacb.com
Media:
pr@pacb.com
Integration Simplifies ICHRA Administration Through HR and Payroll Data SyncINDIANAPOLIS, Jan. 13, 2026 /PRNewswire/ --…
Recognition underscores Brillio's AI-driven innovation and measurable impact on health outcomes, cost, patient experience, and…
Healthcare Technology Leader Received Top Recognition for Innovative Approachto Remote Care for Chronic Disease ManagementSEATTLE,…
PITTSBURGH, Jan. 13, 2026 /PRNewswire/ -- "I wanted to create a simple and easy way…
Tenth annual awards evaluate 24 leading health insurers across 120+ digital attributes spanning desktop and…
More than 100 new and expanded LifeSphere customers, 34 global go-lives, and rapid enterprise adoption…